MetaCap

Acumen Pharmaceuticals Statistics

NASDAQ: ABOSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.1865-0.0068 (-3.52%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Acumen Pharmaceuticals by the numbers

Acumen Pharmaceuticals has a market capitalization of $13.5 million based on 72.33M shares outstanding. With trailing EPS of $-1.55, Acumen Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 88.1% below its 50-day average and 92.1% below its 200-day average.

Average daily trading volume is 2.73M shares, or about $508,653 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ABOS valuation vs. peer median

ABOS compared with the median of 8 peer companies
MetricABOSPeer medianDifference
Market cap$13.49M$12.03M+12%
Avg. volume2.73M167.87K+1525%

Peer median across 8 companies: PLUR, ESLA, PASG, BSEM, BCDA, DYAI, TCRX, ATYR.

Valuation

Price and trading

Previous close
0.1933
Open
0.1861
Day range
0.1601 – 0.1927
52-week range
0.16 – 3.60
52-week change
-88.12%
Beta
—
Volume
2.71M

Dividends and events

Annual dividend
None
Next earnings date
Oct 26, 2026

Additional statistics

Market Cap
13.49M
Forward Pe
-0.38
Eps
-1.55
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
3.60
Week52 Low
0.16
Avg Volume
2.73M
Shares Outstanding
72.33M
Ma50
1.57
Ma200
2.35
Earnings Date
Oct 26, 2026
Pct From52w High
-94.82%
Pct From52w Low
16.56%

Related